These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
249 related articles for article (PubMed ID: 26409286)
21. Recent advances in the research of heterocyclic compounds as antitubercular agents. Yan M; Ma S ChemMedChem; 2012 Dec; 7(12):2063-75. PubMed ID: 23042656 [TBL] [Abstract][Full Text] [Related]
22. Fighting an old disease with modern tools: characteristics and molecular detection methods of drug-resistant Mycobacterium tuberculosis. Engström A Infect Dis (Lond); 2016; 48(1):1-17. PubMed ID: 26167849 [TBL] [Abstract][Full Text] [Related]
23. The future for early-stage tuberculosis drug discovery. Zuniga ES; Early J; Parish T Future Microbiol; 2015; 10(2):217-29. PubMed ID: 25689534 [TBL] [Abstract][Full Text] [Related]
24. Improving the tuberculosis drug development pipeline. Evangelopoulos D; McHugh TD Chem Biol Drug Des; 2015 Nov; 86(5):951-60. PubMed ID: 25772393 [TBL] [Abstract][Full Text] [Related]
25. Evolution of drug resistance in tuberculosis: recent progress and implications for diagnosis and therapy. Trauner A; Borrell S; Reither K; Gagneux S Drugs; 2014 Jul; 74(10):1063-72. PubMed ID: 24962424 [TBL] [Abstract][Full Text] [Related]
26. Drug-resistant tuberculosis in the European Union: opportunities and challenges for control. Fears R; Kaufmann S; Ter Meulen V; Zumla A; Tuberculosis (Edinb); 2010 May; 90(3):182-7. PubMed ID: 20382566 [TBL] [Abstract][Full Text] [Related]
27. Drug-resistant tuberculosis: resistance mechanisms and rapid susceptibility testing. Pfyffer GE Schweiz Med Wochenschr; 2000 Dec; 130(49):1909-13. PubMed ID: 11153397 [TBL] [Abstract][Full Text] [Related]
28. Emerging strategies for the treatment of pulmonary tuberculosis: promise and limitations? Yew WW; Koh WJ Korean J Intern Med; 2016 Jan; 31(1):15-29. PubMed ID: 26767853 [TBL] [Abstract][Full Text] [Related]
29. Recent advances in molecular methods for early diagnosis of tuberculosis and drug-resistant tuberculosis. Hazbón MH Biomedica; 2004 Jun; 24 Supp 1():149-62. PubMed ID: 15495583 [TBL] [Abstract][Full Text] [Related]
30. Early Biomarkers and Regulatory Innovation in Multidrug-Resistant Tuberculosis. Wallis RS; Peppard T Clin Infect Dis; 2015 Oct; 61Suppl 3():S160-3. PubMed ID: 26409278 [TBL] [Abstract][Full Text] [Related]
31. Will molecular diagnosis of drug-resistant tuberculosis improve patient outcomes? Jonsson G; Furin J Int J Tuberc Lung Dis; 2012 Jan; 16(1):4-5. PubMed ID: 22236840 [No Abstract] [Full Text] [Related]
32. [Extensively drug resistant and extremely drug resistant tuberculosis forms after multi-drug resistant tuberculosis: new faces of the old disease]. Baylan O Mikrobiyol Bul; 2011 Jan; 45(1):181-95. PubMed ID: 21341173 [TBL] [Abstract][Full Text] [Related]
33. Trends in discovery of new drugs for tuberculosis therapy. Riccardi G; Pasca MR J Antibiot (Tokyo); 2014 Sep; 67(9):655-9. PubMed ID: 25095807 [TBL] [Abstract][Full Text] [Related]
34. Uniting to end the TB epidemic: advances in disease control from prevention to better diagnosis and treatment. Abubakar I; Lipman M; McHugh TD; Fletcher H BMC Med; 2016 Mar; 14():47. PubMed ID: 27004971 [TBL] [Abstract][Full Text] [Related]
35. Gene mutations in Mycobacterium tuberculosis: multidrug-resistant TB as an emerging global public health crisis. Mishra R; Shukla P; Huang W; Hu N Tuberculosis (Edinb); 2015 Jan; 95(1):1-5. PubMed ID: 25257261 [TBL] [Abstract][Full Text] [Related]
36. New tuberculosis drugs on the horizon. Cole ST; Riccardi G Curr Opin Microbiol; 2011 Oct; 14(5):570-6. PubMed ID: 21821466 [TBL] [Abstract][Full Text] [Related]
37. New and improved diagnostics for detection of drug-resistant pulmonary tuberculosis. O'Grady J; Maeurer M; Mwaba P; Kapata N; Bates M; Hoelscher M; Zumla A Curr Opin Pulm Med; 2011 May; 17(3):134-41. PubMed ID: 21415753 [TBL] [Abstract][Full Text] [Related]